Literature DB >> 7308225

Plasma vasoactive intestinal polypeptide and other regulatory peptides in children with neurogenic tumours.

K Tiedemann, R G Long, J Pritchard, S R Bloom.   

Abstract

Plasma regulatory peptide levels were studied in a group of 21 children with neurogenic tumours and in 22 control children. Plasma vasoactive intestinal polypeptide (VIP) levels were significantly higher in children with neurogenic tumours than in normal children or those with other tumours (p less than 0.05). There was no significant difference between the groups in plasma levels of gastrin, pancreatic glucagon or pancreatic polypeptide. The plasma VIP level may thus be a helpful diagnostic marker for neurogenic tumours in children.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7308225     DOI： 10.1007/bf00441307

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  19 in total

1.  DIARRHEA IN A CHILD WITH A CATECHOLAMINE-SECRETING GANGLIONEUROMA. CASE REPORT AND REVIEW OF THE LITERATUTE.

Authors:  B J ROSENSTEIN; K ENGELMAN
Journal:  J Pediatr       Date:  1963-08       Impact factor: 4.406

2.  Vasoactive intestinal peptide secreting tumors of childhood.

Authors:  S J Kaplan; C T Holbrook; H G McDaniel; W L Buntain; W M Crist
Journal:  Am J Dis Child       Date:  1980-01

Review 3.  Plasma hormone concentrations in gastrointestinal disease.

Authors:  S R Bloom; J M Polak
Journal:  Clin Gastroenterol       Date:  1980-09

4.  Complete maturation of neuroblastoma with bone metastases in documented stages.

Authors:  A L Sitarz; T V Santulli; H J Wigger; W E Berdon
Journal:  J Pediatr Surg       Date:  1975-08       Impact factor: 2.545

5.  Measurement of fasting and postprandial plasma VIP in man.

Authors:  S J Mitchell; S R Bloom
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

6.  Watery diarrhoea and ganglioneuroma with secretion of vasoactive intestinal peptide.

Authors:  P G Swift; S R Bloom; F Harris
Journal:  Arch Dis Child       Date:  1975-11       Impact factor: 3.791

7.  Vasoactive intestinal peptide and its relationship to ganglion cell differentiation in neuroblastic tumors.

Authors:  G Mendelsohn; J C Eggleston; J L Olson; S I Said; S B Baylin
Journal:  Lab Invest       Date:  1979-08       Impact factor: 5.662

8.  Intractable diarrhoea in a patient with vasoactive intestinal peptide-secreting neuroblastoma. Attempted control by somatostatin.

Authors:  K Tiedemann; J Pritchard; R Long; S R Bloom
Journal:  Eur J Pediatr       Date:  1981-10       Impact factor: 3.183

9.  Effect of VIP infusion in water and ion transport in the human jejunum.

Authors:  G J Krejs; J S Fordtran; J Fahrenkrug; O B Schaffalitzky de Muckadell; J E Fischer; C S Humphrey; T M O'Dorisio; S I Said; J H Walsh; A A Shulkes
Journal:  Gastroenterology       Date:  1980-04       Impact factor: 22.682

10.  Experimental evidence for vasoactive intestinal peptide as the cause of the watery diarrhea syndrome.

Authors:  I M Modlin; S R Bloom; S J Mitchell
Journal:  Gastroenterology       Date:  1978-12       Impact factor: 22.682
View more
  1 in total

1.  Intractable diarrhoea in a patient with vasoactive intestinal peptide-secreting neuroblastoma. Attempted control by somatostatin.

Authors:  K Tiedemann; J Pritchard; R Long; S R Bloom
Journal:  Eur J Pediatr       Date:  1981-10       Impact factor: 3.183
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.